In This Section
Project Livin' Label: Venetoclax
Project Livin’ Label: Venetoclax

This episode discusses the development of Venetoclax, which was approved in 2020 to treat newly diagnosed acute myeloid leukemia in combination with azacitidine.

Watch latest episode
Biden Commemorates National Cancer Research Month
Biden Commemorates National Cancer Research Month

A letter from the White House affirmed his support for lifesaving cancer research.

Read the Letter
Science Policy and Government Affairs Events

Learn More
Science Policy and Government Affairs at the AACR Annual Meeting

Learn More
AACR Letters, Policy Documents, and Position Statements

Learn More

From funding research grants to minimizing the barriers to clinical trials, the decisions made in Washington, D.C., directly influence the rate of progress in the war against cancer. Issues regarding health and science are becoming increasingly complex, and competition for limited resources is steadily increasing. These times require that cancer researchers become more actively involved in the policy-making process and take time to educate the public about the exciting progress occurring in the fight against cancer.

The AACR’s principal means for devising and implementing strategies to influence funding and important biomedical research-related public policy issues through The Science Policy and Government Affairs Committee and its subcommittees:

Science Policy and Government Affairs Committee. Provides guidance on public issues of concern to cancer researchers and focuses on mechanisms for speeding up cancer research.